학술논문

Dual targeting of Delta-like ligand 4 (DLL4) and programmed death 1(PD1) inhibits tumor growth and generates enhanced long-term immunological memory
Document Type
Journal
Source
CANCER RESEARCH; AUG 1 2015, 75 1p. Supplement: 15
Subject
Language
English
ISSN
15387445